Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?

BACKGROUND: Lung stereotactic ablative radiotherapy (SABR) is associated with low morbidity, however there is an increased risk of treatment-related toxicity in tumors directly abutting or invading the proximal bronchial tree, termed ‘ultra-central’ tumors. As there is no consensus regarding the opt...

Descripción completa

Detalles Bibliográficos
Autores principales: Murrell, Donna H., Laba, Joanna M., Erickson, Abigail, Millman, Barbara, Palma, David A., Louie, Alexander V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880025/
https://www.ncbi.nlm.nih.gov/pubmed/29606150
http://dx.doi.org/10.1186/s13014-018-1001-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5880025/
https://www.ncbi.nlm.nih.gov/pubmed/29606150
http://dx.doi.org/10.1186/s13014-018-1001-6

Ejemplares similares